Please check your internet connection and try again.
# Urimax (Tamsulosin)
## Overview
Tamsulosin is a selective alpha-1a adrenergic antagonist. It relaxes smooth muscle in the prostate and bladder neck, improving urine flow and reducing obstructive symptoms.
## Primary Indications
- Benign prostatic hyperplasia (BPH)
- Off-label: adjunct for medical expulsive therapy of ureteral stones
## Adult Dosing
- **Initial dose:** 0.4 mg orally once daily, approximately 30 minutes after the same meal each day.
- **Maximum dose:** 0.8 mg once daily (may increase after 2–4 weeks if inadequate response).
- **Duration:** Chronic therapy for BPH; short course (up to 4 weeks) for stone passage.
## Pediatric Dosing
- **Not established.** Safety and efficacy in children have not been determined. Use for ureteral stones in adolescents is off-label and should follow local protocols with specialist guidance; no standard dose validated.
## Dose Adjustments
- **Renal impairment:** No adjustment needed for mild‑to‑moderate impairment. Use caution in severe renal impairment (CrCl <10 mL/min) – limited data.
- **Hepatic impairment:** Avoid in severe hepatic impairment. No dose adjustment recommended for mild‑to‑moderate disease, but use with caution.
- **Elderly:** No routine adjustment; monitor for orthostatic hypotension.
## Contraindications
- History of hypersensitivity to tamsulosin or any component
- History of orthostatic hypotension (including during previous alpha‑blocker therapy)
- Severe hepatic impairment
## Adverse Effects
- **Common:** Dizziness, headache, asthenia, rhinitis, abnormal ejaculation (retrograde or decreased).
- **Serious but rare:** Orthostatic hypotension, syncope, intraoperative floppy iris syndrome (IFIS) during cataract surgery, priapism.
## Key Drug Interactions
- **Other alpha‑blockers:** Additive hypotension – avoid combination.
- **Antihypertensives (especially PDE5 inhibitors like sildenafil, tadalafil):** Increased risk of orthostatic hypotension – separate dosing or reduce doses.
- **CYP3A4 and CYP2D6 inhibitors (e.g., ketoconazole, ritonavir, paroxetine):** May increase tamsulosin levels – monitor or reduce dose.
- **Warfarin:** Limited data suggest possible increased INR – monitor if co‑administered.
## Monitoring
- Blood pressure (especially standing) at initiation and after dose increases
- Symptom improvement (IPSS score)
- Signs of orthostatic hypotension (dizziness, syncope)
- For cataract surgery patients: inform ophthalmologist of tamsulosin use
## Clinical Pearls
- Take consistently 30 minutes after the *same* meal each day to maintain stable absorption.
- Avoid grapefruit juice – may increase tamsulosin exposure.
- If the first dose is missed, take as soon as remembered unless close to next dose; do not double.
- Retrograde ejaculation is a specific side effect; counsel male patients.
- Do not use as first‑line monotherapy in women or children.
**Disclaimer:** This information is for educational purposes. Always verify current prescribing information from an up‑to‑date drug monograph, local formulary, or clinical guidelines before making clinical decisions. Dosing may vary by region and individual patient factors.
